- AU$8.30m
- AU$24.26m
- AU$9.31m
Brief: Cann Group Reports Qtrly Unaudited Sales Revenue Up 57%
Brief: Cann Group Announces Share Purchase Plan
Brief: Cann Group Announces Chief Executive Officer Role Update
Brief: Cann Group Ltd Says Scope Of Mildura GMP Licence Extended
Brief: Cann Group Says FY Operating Loss After Tax Of A$26.47 Mln
Brief: Cann Says FY Revenue And Other Income From Ordinary Activities A$11.2 Million
Brief: Cann Group Says Additional Funding Secured From National Australia Bank
Australia's Cann group jumps most in over 19 months on licence grant
Gmp Manufacturing Licence Granted For Mildura-Can.Ax
Brief: Cann Group Executes Final Documentation To Enter A$15 Mln Working Capital Facility With NAB
Australia's Cann Group hits near 4-month high on manufacturing permit
Australia's Cann Group hits highest in 2 months on GSK Consumer deal
Brief: Cann Group Enters Into Exclusive Evaluation And Option Agreement With Gsk Consumer Healthcare
Notification of cessation of securities - CAN
Australia's Cann Group jumps most in seven months on permit issuance
Brief: Cann Group Says Reached Practical Completion Stage For Production Facility Near Mildura
PRE_NR Ends: 09:09:00
Mildura facility practical completion & ODC permit granted
Cann Group investor presentation